Protecting the beta cells from the autoimmune attack by the immune system may help slow down the progression of type 1 diabetes.
Highlights
- Type 1 diabetes develops when a patient's immune system mistakenly attacks the insulin producing beta cells in the pancreas.
- There is currently no cure for type 1 //diabetes, which can affect major organs in the body, including the heart, blood vessels, nerves, eyes and kidneys.
- A recent trial finds that retraining the immune cells may slow down the progression of type 1 diabetes.
They observed noticeable changes in the behavior of the immune systems of type 1 diabetes patients. Professor Mark Peakman says: "When someone is diagnosed with type 1 diabetes they still typically have between 15% and 20% of their beta cells. We wanted to see if we could protect these remaining cells by retraining the immune system to stop attacking them."
Dr Elizabeth Robertson, Director of Research at Diabetes UK, the charity who supported the lead author of the study, said: "Diabetes UK is committed to increasing our understanding of the immune attack in type 1 diabetes and finding ways to stop it. These new findings are an exciting step towards immunotherapies being used to prevent this serious condition from developing in those at high risk, or stop it from progressing in those already diagnosed."
New Approach To Treat Type 1 Diabetes
Injecting insulin to regulate blood glucose levels after a meal is the only treatment that is followed. But there is no cure for type 1 diabetes. Prolonged high levels of blood glucose levels and the improper management of type 1 diabetes an affect major organs in the body, including the heart, blood vessels, nerves, eyes and kidneys.
"It was encouraging to see that people who receive the treatment needed less insulin to control their blood glucose levels, suggesting that their pancreas was working better" commented, Prof Colin Dayan from Cardiff University, the clinical Chief Investigator for the study.
Reference
- Mark Peakman et al., Pioneering immunotherapy shows promise in type 1 diabetes, Science Translational Medicine (2017).
Source-Medindia